Breast: Page 441

SenoRx prices IPO
By AuntMinnie.com staff writers
Breast cancer interventional device firm SenoRx will offer 5.5 million shares of its common stock in an initial public offering (IPO) at a price of $8 per share.
March 29, 2007
Harvard researchers develop breast cancer contrast agent
By AuntMinnie.com staff writers
Scientists at Harvard Medical School in Cambridge, MA, have developed a contrast agent that selectively targets and highlights malignant microcalcifications in the breast, while ignoring similar microcalcifications found in benign breast conditions.
March 29, 2007
Breast studies: Persistence a must with noncompliant patients; race-based tissue density not a risk factor
By Shalmali Pal
Compliance rates for diagnostic mammography and the effect of race on breast density are highlighted in two studies in the April issue of the American Journal of Roentgenology. While Michigan researchers looked at the costs associated with a system designed to encourage patients to return for additional imaging, a group in Massachusetts sought to determine if innate racial differences in breast density might explain differences in breast cancer risk.
March 29, 2007
Aurora gets California install
By AuntMinnie.com staff writers
Breast MRI technology developer Aurora Imaging Technology has installed its dedicated 1.5-tesla scanner at Aurora Breast MRI of Orange County.
March 28, 2007
ACS advocates breast MR screening for high-risk women
By AuntMinnie.com staff writers
Women with a genetic predisposition to breast cancer, and/or those with a family history of the disease, should undergo annual MR screening along with routine mammograms, according to a new guideline released by the American Cancer Society (ACS).
March 27, 2007
Dilon sales grow in Q4
By AuntMinnie.com staff writers
Gamma camera developer Dilon Technologies of Newport News, VA, said that its fiscal 2006 fourth quarter saw strong sales for its breast-specific gamma camera.
March 27, 2007
Siemens to sell U-Systems breast US scanner
By AuntMinnie.com staff writers
Siemens Medical Solutions has signed a deal giving the Malvern, PA, vendor worldwide rights to distribute the SomoVu breast ultrasound scanner from U-Systems of San Jose, CA.
March 25, 2007
Medipattern integrates B-CAD with Sectra
By AuntMinnie.com staff writers
Computer-aided detection (CAD) software developer Medipattern of Toronto has integrated its B-CAD application with Swedish technology developer Sectra's breast imaging workstation.
March 21, 2007
Molecular markers: Putting too fine a point on DCIS?
By Shalmali Pal
KEY LARGO, FL - The great promise of genetic testing and molecular markers may be all the rage right now, but that doesn't mean good old-fashioned imaging and pathology will fall by the wayside. At least that's the opinion of an expert panel at the Breast Course 2007 this week that discussed the role genetic information will play for assessing ductal carcinoma in situ (DCIS).
March 14, 2007
Spiral MRI technique picks up what mammo misses in DCIS
By Shalmali Pal
KEY LARGO, FL - Microcalcifications are a signpost of ductal carcinoma in situ (DCIS) on mammography and in pathological studies. But microcalcifications do not always correlate with disease extent, which means DCIS may be missed. At the Breast Course 2007, Dr. Steve Harms explained why one particular MRI technique can go where mammography can't in diagnosing DCIS.
March 14, 2007
Sonography expands its role in evaluating nipple discharge
By Shalmali Pal
KEY LARGO, FL - Ultrasound can be used as a first-line imaging tool for diagnosing papillomas and other benign breast disorders, allowing clinicians to skip the more invasive galactography exam. But using ultrasound successfully to assess nipple discharge requires the right skill set, according to a presentation Tuesday at the Breast Course 2007.
March 13, 2007
Breast pathology lacks standardization, particularly in DCIS
By Shalmali Pal
KEY LARGO, FL - Part and parcel of good pathologic results is the correlation of pathology with mammography, especially in cases of ductal carcinoma in situ (DCIS). Unfortunately, pathology practice is not always done at the most optimal level, according to a speaker at the Breast Course 2007. Dr. Michael Lagios discussed how suboptimal pathology can affect clinical outcomes.
March 12, 2007
Previous Page
Page 441 of 579
Next Page